A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of rapid British shipping. Vendors market the drug there before redirecting buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Express Concerns
However, physicians and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.
Some professionals stated the demand for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or prison.
Platform Response and Material Removal
Based on the social media company, the platform has removed violative material and banned associated keywords and query recommendations. The company said it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed guides for preparing or administering at home.
Within minutes of entering one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, health issues or past usage.
Product Information and Costs
Inside these communities, posts show dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious medical dangers”.
